| scholarly article | Q13442814 |
| P50 | author | Rita Cowell | Q42650528 |
| P2093 | author name string | James W Russell | |
| Pratik Talati | |||
| James H Meador-Woodruff | |||
| Kathryn R Blake | |||
| P2860 | cites work | Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood | Q24541484 |
| PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis | Q24798075 | ||
| PGC-1beta in the regulation of hepatic glucose and energy metabolism | Q28566796 | ||
| The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 alpha and cAMP-response element-binding protein (CREB) | Q28572804 | ||
| Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain | Q28576617 | ||
| Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice | Q29614547 | ||
| Mitochondrial dynamics and apoptosis | Q29616570 | ||
| Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila | Q29616737 | ||
| Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators | Q29617353 | ||
| Histone deacetylase inhibitors reduce polyglutamine toxicity | Q33953013 | ||
| The energetics of Huntington's disease | Q34308028 | ||
| The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? | Q34630060 | ||
| Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha ) and mitochondrial function by MEF2 and HDAC5 | Q34761571 | ||
| Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease | Q34763178 | ||
| Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. | Q35041054 | ||
| Histone deacetylase inhibitors as therapeutics for polyglutamine disorders | Q36599926 | ||
| PGC-1alpha, a new therapeutic target in Huntington's disease? | Q36643257 | ||
| Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis | Q37526796 | ||
| Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells | Q40649634 | ||
| Regulation of PGC-1alpha and PGC-1alpha-responsive genes with forskolin-induced Schwann cell differentiation | Q41641743 | ||
| PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells | Q42478723 | ||
| Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice | Q44619618 | ||
| Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease | Q45115023 | ||
| Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. | Q45302702 | ||
| Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration | Q45302924 | ||
| Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells | Q46870176 | ||
| P433 | issue | 2 | |
| P921 | main subject | neuroblastoma | Q938205 |
| P304 | page(s) | 578-582 | |
| P577 | publication date | 2008-12-30 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells | |
| P478 | volume | 379 |
| Q90721199 | A Role for PGC-1α in Transcription and Excitability of Neocortical and Hippocampal Excitatory Neurons |
| Q50421506 | Cell-specific deletion of PGC-1α from medium spiny neurons causes transcriptional alterations and age-related motor impairment |
| Q39009182 | Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions |
| Q37139004 | Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia |
| Q37112008 | Dietary whey protein stimulates mitochondrial activity and decreases oxidative stress in mouse female brain |
| Q33799027 | Mice lacking the transcriptional coactivator PGC-1α exhibit alterations in inhibitory synaptic transmission in the motor cortex. |
| Q42738266 | Mitochondria and PGC-1α in Aging and Age-Associated Diseases |
| Q96304531 | Natural products, PGC-1 α , and Duchenne muscular dystrophy |
| Q50212482 | Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons |
| Q34383492 | PGC-1α provides a transcriptional framework for synchronous neurotransmitter release from parvalbumin-positive interneurons |
| Q33623182 | PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy. |
| Q33922914 | Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha |
| Q64962182 | Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD+-dependent SIRT1-PGC-1α-TFAM pathway. |
| Q33581698 | Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts |
Search more.